| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| FB23 |
FB23 |
2243736-35-6 |
詳細
|
| ZUN97585,FGFR1/DDR2 inhibitor 1 |
FGFR1/DDR2 inhibitor 1 |
2308497-58-5 |
詳細
|
| Ro0711401 |
化合物RO0711401 |
714971-87-6 |
詳細
|
| JTZ-951 |
依那度他 |
1262132-81-9 |
詳細
|
| WAY-262611 |
MAY-262611 |
1123231-07-1 |
詳細
|
| TCKHNS11 |
TC KHNS 11 |
1431540-99-6 |
詳細
|
| SRS11-92 |
化合物SRS11-92 |
1467047-25-1 |
詳細
|
| Evatanepag (CP-533536) |
2-[3-[N-(4-叔丁基芐基)-N-(吡啶-3-基磺?；?氨基甲基]苯氧基]乙酸 |
223488-57-1 |
詳細
|
| (Rac)-IBT6A |
1412418-47-3 |
1412418-47-3 |
詳細
|
| XL019 |
XL019 |
945755-56-6 |
詳細
|
| JNJ-40411813 |
JNJ40411813 |
1127498-03-6 |
詳細
|
| Ah 6809 |
6-異丙氧基-9-氧代氧雜蒽-2-羧酸 |
33458-93-4 |
詳細
|
| PDD 00017273 |
1945950-21-9 |
1945950-21-9 |
詳細
|
| N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
354126-20-8 |
詳細
|
| BMS-1001 |
BMS-1001鹽酸鹽 |
2113650-04-5 |
詳細
|
| CX-6258Hydrochloride |
CX-6258HCL |
1353859-00-3 |
詳細
|
| DDD107498 Fumarate |
|
|
詳細
|
| JNJ-47965567 |
N-[[4-(4-PHENYLPIPERAZIN-1-YL)OXAN-4-YL]METHYL]-2-PHENYLSULFANYLPYRIDINE-3-CARBOXAMIDE |
1428327-31-4 |
詳細
|
| KL001 |
N-(3-(9H-咔唑-9-基)-2-羥基丙基)-N-(呋喃-2-基甲基)甲烷磺酰胺 |
309928-48-1 |
詳細
|
| SNS-314 Mesylate |
N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸鹽 (1:1) |
1146618-41-8 |
詳細
|
| BCATcInhibitor2 |
5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide |
406191-34-2 |
詳細
|
| LH846 |
LH-846 |
639052-78-1 |
詳細
|
| PF-06409577 |
PF-06409577 |
1467057-23-3 |
詳細
|
| Rec 15-2739 |
UPIDOSIN |
152735-23-4 |
詳細
|
| Pavinetant |
941690-55-7 |
941690-55-7 |
詳細
|
| Ibiglustat L-Malic acid |
1629063-78-0 |
1629063-78-0 |
詳細
|
| URB597 (KDS-4103) |
URB597 |
546141-08-6 |
詳細
|
| PD-1/PD-L1-IN-NP19 |
化合物PD-1/PD-L1-IN-NP19 |
2377916-66-8 |
詳細
|
| CP-640186 Hydrochloride |
鹽酸CP-640186 |
591778-70-0 |
詳細
|
| SBI-0640756 |
CS-2838 |
1821280-29-8 |
詳細
|
| NPD8733 |
化合物NPD8733 |
696655-62-6 |
詳細
|
| CVT-11127 |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氫吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
詳細
|
| 1383373-65-6 |
化合物T60041 |
1383373-65-6 |
詳細
|
| ML-193 |
ML193 |
713121-80-3 |
詳細
|
| TAK-285 |
TAK285 |
871026-44-7 |
詳細
|
| ML390 |
化合物ML390 |
2029049-79-2 |
詳細
|
| Lanraplenib |
GS-9876 |
1800046-95-0 |
詳細
|
| PRX-08066 Maleic acid |
PRX-08066 |
866206-55-5 |
詳細
|
| NVR 3-778 |
4-fluoro-3-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide |
1445790-55-5 |
詳細
|
| AD57 |
化合物AD57 |
1093380-42-7 |
詳細
|
| RS 25344 HCl |
1-(3-硝基苯基)-3-(吡啶-4-基甲基)吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮鹽酸鹽 |
152815-28-6 |
詳細
|
| N-[3-[(4-Fluorophenyl)sulfonylamino]-4-methoxyphenyl]-4-phenylbenzamide |
N-(3-(4-氟苯基磺酰氨基)-4-甲氧基苯基)-[1,1'-聯(lián)苯]-4-甲酰胺 |
727699-84-5 |
詳細
|
| APS6-45 |
化合物APS6-45 |
2188236-41-9 |
詳細
|
| HM43239 |
化合物HM43239 |
2569527-64-4 |
詳細
|
| AD80 |
AD80 |
1384071-99-1 |
詳細
|
| AM095 sodium |
4'-[3-甲基-4-[[[(1R)-1-苯基乙氧基]羰基]氨基]-5-異惡唑基]聯(lián)苯-4-乙酸鈉鹽 |
1345614-59-6 |
詳細
|
| BIBF 1202 |
BIBF 1202 |
894783-71-2 |
詳細
|
| Z433927330 |
Z433927330 |
1005883-72-6 |
詳細
|
| AST-1306 |
AST-1306 |
897383-62-9 |
詳細
|
| GDC046 |
GDC-046;GDC 046 |
1258292-64-6 |
詳細
|
| UNC2250 |
反式-4-[[2-(丁基氨基)-5-[5-(4-嗎啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]環(huán)己醇 |
1493694-70-4 |
詳細
|
| K-7174 dihydrochloride |
K-7174 |
191089-60-8 |
詳細
|
| 2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)- |
ML-277 |
1401242-74-7 |
詳細
|
| N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide |
BAY1834845 |
1931994-81-8 |
詳細
|
| 1-Benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea |
SRI011381 |
1629138-41-5 |
詳細
|
| ML364 |
2-(4-甲基苯磺胺基)-N-(4-苯基噻唑-2-基)-4-三氟甲基苯甲酰胺 |
1991986-30-1 |
詳細
|
| XEN-445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
詳細
|
| ML348 |
CS-2370 |
899713-86-1 |
詳細
|
| 13MT-3 |
4(3H)-Pyrimidinone, 6-methyl-2-[[2-(1-naphthalenyl)-2-oxoethyl]thio]- |
459420-09-8 |
詳細
|
| At listatin |
ATGLISTATIN |
1469924-27-3 |
詳細
|
| SK4112 |
1216744-19-2 |
1216744-19-2 |
詳細
|
| (R)-CR8 trihydrochloride |
(R)-CR8 (trihydrochloride) |
1786438-30-9 |
詳細
|
| ELN-441958 |
ELN 441958 |
913064-47-8 |
詳細
|
| ITX5061 |
1252679-52-9 |
1252679-52-9 |
詳細
|
| Lodenafil (Hydroxyhomosildenafil) |
羥基豪莫西地那非 |
139755-85-4 |
詳細
|
| MALAT1-IN-1 |
MALAT1 inhibitor 5
(Malat1 inhibitor 5) |
827327-28-6 |
詳細
|
| 1093070-10-0 |
化合物TC-067533 |
1093070-10-0 |
詳細
|
| AZD-26 |
6-[4-(1-氨基環(huán)丁基)苯基]-5-苯基-3-吡啶甲酰胺 |
1357158-81-6 |
詳細
|
| Rasarfin |
化合物RASARFIN |
674359-73-0 |
詳細
|
| PW0787 |
1-(6-(3-氟-5-(三氟甲基)芐基)嘧啶-4-基)-N-(2-羥乙基)吲哚啉-4-甲酰胺 |
2624131-45-7 |
詳細
|
| RORγt inverse agonist 13 |
化合物RORΓT INVERSE AGONIST 13 |
2170477-75-3 |
詳細
|
| (Rac)-MGV354 |
MGV354 |
1852495-86-3 |
詳細
|
| SBP-3264 |
SBP-3264 |
|
詳細
|
| AZD2858 |
AZD2858 |
486424-20-8 |
詳細
|
| Pyribencarb |
甲基{2-氯-5-[(1E)-1-(6-甲基-2-吡啶基-甲氧亞胺基)乙基-芐基氨基甲酸酯 |
799247-52-2 |
詳細
|
| 9-ING-41 |
9-ING-41 |
1034895-42-5 |
詳細
|
| AZD7545 |
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羥基-2-甲基-1-氧代丙基]氨基]苯基]磺?；鵠-N,N-二甲基苯甲酰胺 |
252017-04-2 |
詳細
|
| N-(2-Aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-1-naphthalenecarboxamide |
1-Naphthalenecarboxamide, N-(2-aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]- |
1256349-48-0 |
詳細
|
| ML162 |
ML162 |
1035072-16-2 |
詳細
|
| ADAMTS-5 |
ADAMTS-5 |
929634-33-3 |
詳細
|
| EPPTB |
化合物EPPTB |
1110781-88-8 |
詳細
|
| Samelisant (SUVN-G3031) |
SUVN-G3031 |
1394808-82-2 |
詳細
|
| GW 590735 |
化合物GW590735 |
343321-96-0 |
詳細
|
| Bersacapavir (JNJ-56136379) |
化合物 T32308 |
1638266-40-6 |
詳細
|
| CC618 |
化合物CC618 |
1680204-90-3 |
詳細
|
| PF-06446846 hydrochloride |
PF-06446846 |
1632250-50-0 |
詳細
|
| Oncrasin 1 |
1-(4-氯芐基)-1H-吲哚-3-甲醛 |
75629-57-1 |
詳細
|
| PF-06687859/R -3039 |
5-[[1-(2,6-二氯芐基)哌啶-4-基]甲氧基]喹唑啉-2,4-二胺 |
1005504-62-0 |
詳細
|
| BML-284 |
WNT AGONIST 1 (CID11210285 鹽酸鹽) |
853220-52-7 |
詳細
|
| TAK-615 |
化合物TAK-615 |
1664335-55-0 |
詳細
|
| NITD-2 |
化合物NITD-2 |
1197896-79-9 |
詳細
|
| BML 280 |
消旋-7-氧代普拉克索二鹽酸鹽 |
1158347-73-9 |
詳細
|
| TJ-M2010-5 |
化合物TJ-M2010-5 |
1357471-57-8 |
詳細
|
| 126766-43-6 |
(R)-Methyl 4-(2-(3,4-dichlorophenyl)acetyl)-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate fumarate |
126766-43-6 |
詳細
|
| GLP-1R modulator L7-028 |
化合物GLP-1R MODULATOR L7-028 |
2648317-95-5 |
詳細
|
| JAK-IN-14 |
化合物JAK-IN-14 |
1973485-06-1 |
詳細
|
| AWL-II-38.3 |
化合物AWL-II-38.3 |
1135205-94-5 |
詳細
|
| ADH-503 |
Benzoic acid, 4-[5-[(Z)-[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]- |
2055362-72-4 |
詳細
|
| SR33805 |
SR 33805 |
121345-64-0 |
詳細
|
| S18-000003 |
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
2068119-11-7 |
詳細
|